ArticleCureus2025
Outcomes of Below-Elbow Versus Above-Elbow Immobilization in the Management of a Partial Triangular Fibrocartilage Complex Tear Without Distal Radio-Ulnar Joint Disruption: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The triangular fibrocartilage complex (TFCC) is a crucial biomechanical structure that supports the distal radioulnar joint (DRUJ), forearm rotation, and load transfer along the ulnar aspect of the wrist. Conservative treatment is the preferred approach for managing stable TFCC injuries, but the techniques of immobilization remain a topic of debate. This study aims to evaluate whether above-elbow immobilization provides better pain relief, functional recovery, and fewer complications than below-elbow immobilization in the conservative treatment of partial TFCC tears without DRUJ disruption. Materials and methods A total of 52 patients treated at R.L. Jalappa Hospital and Research Centre, Kolar, India, from February 2024 to January 2025, who had magnetic resonance imaging (MRI)-confirmed partial tears of the TFCC without DRUJ instability, were retrospectively reviewed. The patients were divided into two groups: Group A (n = 26) was managed using below-elbow immobilization with a slab, splint, or cast, while Group B (n = 26) was managed using above-elbow immobilization with a slab, splint, or cast. Initial immobilization was done for six weeks, followed by a two-week period of wearing a wrist brace. After that, range of motion (ROM) exercises were performed over a period of seven to eight weeks, along with a structured rehabilitation program from weeks 9 to 16. Outcome measures of pain were assessed using the Visual Analog Scale (VAS), upper limb function using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, and wrist-specific outcomes using the Patient-Rated Wrist Evaluation (PRWE) score at baseline, and at 6, 12, and 24 weeks, respectively. Complications were recorded throughout the study period. Results At each follow-up visit, Group B exhibited lower VAS (0.9 vs. 1.7), DASH (10.8 vs. 13.4), and PRWE scores (14.2 vs. 17.6). Group A had 10 patients (38.5%) with complications, whereas Group B had seven patients (26.9%) with complications. Conclusion In cases of partial tears of the TFCC without DRUJ disruption, the clinical outcomes with above-elbow immobilization are superior to those with below-elbow immobilization over a 24-week follow-up. Based on these findings, limiting supination and pronation of the forearm in the early stage is crucial for effective healing and functional recovery in partial TFCC injuries, and a tailored treatment plan, along with structured rehabilitation, is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.